Funding supports research to improve human health
Ron Jachimowicz, head of the research group "Mechanisms of DNA Repair" at the Max Planck Institute for Biology of Ageing, receives funding from the Behrens-Weise Foundation. The foundation supports research in the fields of biology and medicine that serves to improve and maintain human health. Jachimowicz's group is researching DNA repair to achieve a better understanding of the connections between genome maintenance, ageing and cancer.
Our genome needs constant repair to ensure the correct transmission of genetic information to our offspring. An extensive network of DNA repair pathways ensures that the consequences of DNA damage are kept to a minimum. Defects in DNA repair pathways promote genome instability and are a central cause of ageing and the development of cancer.
Jachimowicz's group is investigating defects in DNA repair pathways in patients with genome instability syndromes and in patients suffering from mantle cell lymphomas. They combine this with tools from cell biology and genetics. In the long term, this interdisciplinary approach should lead to new therapies for patients with cancer and other age-associated diseases.
About Ron Jachimowicz
Jachimowicz studied medicine at the University of Cologne from 2003 to 2010 and then worked as an assistant physician in Clinic I for Internal Medicine (haematology, oncology and infectiology) at the University Hospital Cologne. In 2013, he moved to the CECAD cluster of excellence at the University of Cologne as a postdoc and spent three years as a postdoc at the Sackler School of Medicine at Tel Aviv University in Israel from 2014. In 2017, he returned to Germany and resumed his work at CECAD and University Hospital in Cologne. Since 2020, Jachimowicz has been Max Planck Research Group Leader at the Max Planck Institute for Biology of Ageing and Senior Physician in Clinic I for Internal Medicine at the University Hospital in Cologne.
About the Behrens-Weise Foundation
The Behrens-Weise-Foundation emerged from the legacy of Anna Weise and promotes scientific research in the fields of biology and medicine that serves to improve and maintain human health and the exchange between German and international researchers in the fields. The foundation funds projects with 50,000 EUR per year for 3 years. The recipients of this funding must be heads of Max Planck research groups or independent research group leaders at Max Planck Institutes.